Connor, Clark & Lunn Investment Management (CC&L)’s Treace Medical Concepts TMCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Buy |
99,215
+16,726
| +20% | +$98.3K | ﹤0.01% | 1208 |
|
|
2025
Q1 | $692K | Buy |
82,489
+36,566
| +80% | +$307K | ﹤0.01% | 1060 |
|
|
2024
Q4 | $342K | Buy |
+45,923
| New | +$342K | ﹤0.01% | 1234 |
|
|
2024
Q2 | – | Sell |
-95,008
| Closed | -$1.24M | – | 1692 |
|
|
2024
Q1 | $1.24M | Sell |
95,008
-1,226
| -1% | -$16K | 0.01% | 819 |
|
|
2023
Q4 | $1.23M | Buy |
96,234
+5,266
| +6% | +$67.1K | 0.01% | 802 |
|
|
2023
Q3 | $1.19M | Buy |
90,968
+40,048
| +79% | +$525K | 0.01% | 770 |
|
|
2023
Q2 | $1.3M | Buy |
50,920
+18,606
| +58% | +$476K | 0.01% | 717 |
|
|
2023
Q1 | $814K | Buy |
32,314
+8,782
| +37% | +$221K | ﹤0.01% | 769 |
|
|
2022
Q4 | $541K | Buy |
+23,532
| New | +$541K | ﹤0.01% | 844 |
|